期刊文献+

PSA>4.0 μg/L在高原地区藏族人群中前列腺癌的诊断 被引量:1

Diagnosis of prostate cancer with PSA>4.0 μg/L at high altitude in Tibetan population
在线阅读 下载PDF
导出
摘要 目的评估前列腺特异性抗原(PSA)相关标志物对高原地区PSA>4.0μg/L藏族人群前列腺癌(PCa)的诊断价值。方法回顾性分析2014年10月~2016年10月西藏自治区人民医院泌尿外科就诊的110例PSA>4.0μg/L的藏族人群前列腺穿刺的病理结果,年龄50~100岁,将患者按PSA含量4.1~10.0μg/L、10.1~20.0μg/L、20.1~50.0μg/L、>50.0μg/L分为4组;同时将年龄分为4组:50~59岁、60~69岁、70~79岁、≥80岁,评价游离前列腺特异性抗原/总前列腺特异性抗原(f-PSA/t-PSA)、前列腺特异性抗原密度(PSAD)诊断不同PSA水平下藏族人前列腺癌的价值及不同年龄段不同PSA水平下藏族人PCa的检出率。结果 110例患者中PCa检出率9.1%(10/110)。PSA含量4.1~10.0μg/L、10.1~20.0μg/L、20.1~50.0μg/L、>50.0μg/L时PCa的检出率分别是:1.8%(1/55)、3.8%(1/26)、4.8%(1/21)、87.5%(7/8);f-PSA/t-PSA、PSAD在前列腺癌与非前列腺癌患者之间差异具有统计学意义(P<0.05),但在不同的PSA区间内因PCa样本数量太少,无法进行比较;而各个年龄段的检出率比较差异无统计学意义。结论 PSA>4.0μg/L的藏族人群中f-PSA/t-PSA、PSAD能有效诊断前列腺癌,但特异性不高。 Objective To evaluate prostate-specific antigen(PSA) related markers in the diagnosis of prostate cancer(PCa) with PSA>4.0 μg/L in Tibetan population at high altitude in Lasa. Methods We reviewed the prostate biopsy examination data of Tibetan population from October 2014 to October 2016, a total of 110 subjects with PSA>4.0 μg/L, aged 50-100 years. According to the levels of PSA, the subjects were divided into four groups: 4.1-10.0 μg/L, 10.1-20.0 μg/L, 20.1-50.0 μg/L, >50.0 μg/L.The diagnostic values of free/total(f-PSA/t-PSA) and PSA density(PSAD) were assessed in different PSA levels. According to the age, the subjects were divided into four groups: 50-59 yr, 60-69 yr, 70-79 yr, ≥80 yr. The rates of PCa detection with different PSA levels were assessed in different age groups. Results The rates of PCa detection is 9.1%(10/110) in these 110 subjects, with detection rates of 1.8%(1/55), 3.8%(1/26), 4.8%(1/21), 87.5%(7/8) in these different PSA levels of 4.1-10.0 μ g/L, 10.1-20.0 μg/L, 20.1-50.0 μg/L, >50.0 μg/L. There were significant difference in f-PSA/t-PSA and PSAD between the PCa patients and non-PCa patients(P<0.05). But the PCa patients in different PSA levels were too little to compare with f-PSA/t-PSA or PSAD; there were no significant difference in different age groups. Conclusion f-PSA/t-PSA and PSAD can effective diagnosis of PCa with the PSA>4.0 μg/L, but the specificity is not enough.
出处 《当代医学》 2018年第5期7-9,共3页 Contemporary Medicine
关键词 前列腺癌 前列腺特异性抗原 年龄 藏族人群 Prostate cancer Prostate-specific antigen Age Tibetan population
  • 相关文献

参考文献5

二级参考文献35

  • 1Stefano Arcangeli,Valentina Pinzi,Giorgio Arcangeli.Epidemiology of prostate cancer and treatment remarks[J].World Journal of Radiology,2012,4(6):241-246. 被引量:18
  • 2高中伟.血清PSA的影响因素[J].现代泌尿外科杂志,2001,6(2):60-62. 被引量:9
  • 3李培军,张祥华,郭利君,那彦群.血清PSA与良性前列腺增生临床病理的相关性研究[J].中华泌尿外科杂志,2006,27(6):421-423. 被引量:14
  • 4Yamamoto S, Kin U, Nakanmra K, et al. Transperinealul- trasound- guided 12 -eore systematic biopsy of the prostate for patients with a prostate - specific antigen levelof 2.5 -20 ng/ml in Japan [ J ]. Int J Clin Oncol, 2005,10 : 117-121.
  • 5Stamey TA, Caldwell M, MeNeal JE, et al. The prostate specific antigen era in the united state is over for prostate cancer: what happened in the last 20 years [ J ] ? J Uro1,2004,172 : 1297-1301.
  • 6BJ Rkt, Bjartella,Abrahamsson PA, et al. Alpha 1 - an- tichymotrypsin production in PSA - producing ceils is common in prostate cancer but rare in benign prostatic hyperplasia[J].Urology, 1994,43 (4) :427-434.
  • 7Bosch JH,Hop WC. Community - based sample of men without prostate cancer: Correlations with prostate vol- ume,age,body mass index, and symptoms of prostatism[J].Prostate, 1995,27:241-249.
  • 8王寅 黄长海 等.前列腺特异抗原不同评价结果与前列腺癌的关系分析[J].中华医学杂志,2000,80(9):678-680.
  • 9Morgan TO, Jacobsen SJ, McCarthy WF, et al. Age-specific reference ranges for prostate-specific antigen in black men. N Engl J Med, 1996, 335: 304-310.
  • 10Oesterling JE, Jacobsen SJ, Chute CG, et al. Serum prostate-specific antigen in a community-based population of healthy men: establishment of age-specific reference ranges. JAMA, 1993, 270:860-864.

共引文献883

同被引文献23

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部